Cargando…

Country-based report: the safety of omalizumab treatment in pregnant patients with asthma

BACKGROUND/AIM: We aimed to report outcomes of pregnant patients with asthma under omalizumab treatment and their infants in our country. MATERIALS AND METHODS: Patients with asthma who received omalizumab for at least 6 months and at least one dose during their pregnancy were retrospectively evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	GEMİCİOĞLU, Bilun, YALÇIN, Arzu Didem, HAVLUCU, Yavuz, KARAKAYA, Gül, ÖZDEMİR, Levent, KEREN, Metin, BAVBEK, Sevim, EDİGER, Dane, OĞUZÜLGEN, İpek Kıvılcım, ÖZŞEKER, Zeynep Ferhan, YORGANCIOĞLU, Arzu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742481/ https://www.ncbi.nlm.nih.gov/pubmed/34174791 http://dx.doi.org/10.3906/sag-2101-341

Ejemplares similares

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Knowledge Level of the Primary Healthcare Providers on Chronic Obstructive Pulmonary Disease and Pulmonary Rehabilitation
por: Göktalay, Tuğba, et al.
Publicado: (2015)

Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone
por: Uzun, Rusen, et al.
Publicado: (2016)

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

277 Serum Soluble Trail Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases
por: Celebi Sozener, Zeynep, et al.
Publicado: (2018)

Is It Possible to Predict Pulmonary Complications and Mortality in Hematopoietic Stem Cell Transplantation Recipients from Pre-Transplantation Exhaled Nitric Oxide Levels?
por: Köktürk, Nurdan, et al.
Publicado: (2016)

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Short-acting β(2)-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III
por: Yorgancıoğlu, Arzu, et al.
Publicado: (2022)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps
por: Bagnasco, Diego, et al.
Publicado: (2022)

An Overview of the Effects of anti-IgE Therapies
por: Yalcin, Arzu Didem
Publicado: (2014)

Advances in Anti-IgE Therapy
por: Yalcin, Arzu Didem
Publicado: (2015)

278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

The effects of climate and aero allergens changes in allergic rhinoconjunctivitis and allergic asthma patients in mediterranean region between 2011 and 2012
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Can development of asthma and bronchial hyperreactivity be reduced by subcutaneous immunotherapy in adult patients with allergic rhinitis?
por: TEPETAM, Fatma Merve, et al.
Publicado: (2023)

Attitude and Practice Toward Use of Cigarettes and Electronic Cigarettes Among Pregnant Women: A Questionnaire-Based Survey
por: Yıldırım, Elif, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Diagnosis of Lung Cancer
por: Kızılırmak, Deniz, et al.
Publicado: (2022)

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

The Global Alliance against Chronic Respiratory Diseases: journey so far and way ahead
por: Yorgancioglu, Arzu, et al.
Publicado: (2020)

Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study
por: Suerdem, Mecit, et al.
Publicado: (2020)

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Environmental and occupational respiratory diseases – 1062. The climate and aero allergens in Mediterranean region and allergen sensitivity in allergic rhinoconjuctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes
por: Gemicioglu, Bilun, et al.
Publicado: (2014)

Common variable immunodeficiency syndrome with right aortic arch: a case report
por: Yalcin, Arzu Didem, et al.
Publicado: (2004)

Cardiac allergy (Kounis Syndrome) and loss of motor neural sensaton during local anesthetic skin test
por: Ozseker, Zeynep Ferhan, et al.
Publicado: (2015)

Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing
por: Özsoy, Sevim, et al.
Publicado: (2017)

The effects of very early mirror therapy on functional improvement of the upper extremity in acute stroke patients
por: Yeldan, Ipek, et al.
Publicado: (2015)

Allergic diseases of the skin and drug allergies – 2027. Successful treatment with intravenous immunoglobulin and prednisolone pulse therapy of toxic epidemal necrolysis and Stevens-Johnson Syndrome
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

One-step synthesis of hierarchical [B]-ZSM-5 using cetyltrimethylammonium bromide as mesoporogen
por: KARAKAYA YALÇIN, Büşra, et al.
Publicado: (2020)

Rituximab Hypersensitivity: From Clinical Presentation to Management
por: Fouda, Ghada E., et al.
Publicado: (2020)

Clinical Characteristics and Prognostic Factors of Patients With Stenotrophomonas maltophilia Pneumonia: 10-Year Experience From a Single Center
por: Kızılırmak, Deniz, et al.
Publicado: (2023)

Coincidence of pollen season and coronavirus disease 2019 pandemic: less time outdoors – lesser allergy symptoms in 2020
por: Sözener, Zeynep Çelebi, et al.
Publicado: (2021)

The incidence and severity of pulmonary hypertension in obstructive sleep apnea with hypothyroidism
por: Araz, Omer, et al.
Publicado: (2013)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_703lbuodks3h4cjup7s0qu10r9